MYGN

Myriad Genetics Stock Analysis

AI Rating

Low
  • Quality2/10
  • Growth↓ 0/10
  • Value↓ 3/10
Myriad Genetics sales and earnings growth
MYGN Growth
Low
  • Revenue Y/Y↓ -1.56%
  • EPS Y/Y↓ -180.14%
  • FCF Y/Y↑ 33.33%
Myriad Genetics gross and profit margin trends
MYGN Profitability
Low
  • Gross margin ↑ 69.90%
  • EPS margin↓ -44.40%
  • ROIC 5Y↓ -60.94%
Myriad Genetics net debt vs free cash flow
MYGN Risk
Great
  • Debt / Equity↓ 0.6
  • Debt / FCF↓ 2.4
  • Interest coverage↓ -36.6

Myriad Genetics stock volatility is in-line with the overall market. We give it a Great risk rating.

More Diagnostics & Research stocks ↗